Andere Sprachen bluebird bio, Inc.

Aktien

A1W025

US09609G1004

BLUE

Verzögert Nasdaq Andere Börsenplätze 21:51:47 24.04.2024			% 5 Tage	% 1. Jan.
0.9269 ^USD	-4.50%		-3.79%	-32.84%

27.03.	BLUEBIRD BIO, INC. : Wells Fargo Securities bleibt neutral	ZM
27.03.	BLUEBIRD BIO, INC. : Wedbush gibt eine neutrale Bewertung ab	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit	21:16
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm	23.04.
Lost Money on bluebird bio, Inc.(BLUE)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky	22.04.
ROSEN, LEADING TRIAL ATTORNEYS, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE	21.04.
Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUE	20.04.
Bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BLUE	19.04.
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit	18.04.
ROSEN, NATIONAL TRIAL LAWYERS, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE	17.04.
May 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BLUE	17.04.
Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The Gross Law Firm	16.04.
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit	15.04.
Bluebird bio, Inc. Class Action: Levi & Korsinsky Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 - BLUE	15.04.
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUE	13.04.
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against BlueBird Bio, Inc. (NASDAQ: BLUE)	12.04.
BLUE Shareholders with Significant Losses are Urged to Contact Robbins LLP to Discuss the bluebird bio, Inc. Class Action	12.04.
Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUE	12.04.
Bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)	12.04.
Shareholders that lost money on bluebird bio, Inc.(BLUE) Urged to Join Class Action - Contact The Gross Law Firm to Learn More	12.04.
Bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	11.04.
ROSEN, A TOP RANKED LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE	11.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen bluebird bio, Inc.

Aktien

A1W025

US09609G1004

BLUE

Andere Sprachen

Filter